PMID- 27965105
OWN - NLM
STAT- MEDLINE
DCOM- 20170214
LR  - 20211204
IS  - 2352-3964 (Electronic)
IS  - 2352-3964 (Linking)
VI  - 15
DP  - 2017 Feb
TI  - Factors Associated with Sequelae of Campylobacter and Non-typhoidal Salmonella 
      Infections: A Systematic Review.
PG  - 100-111
LID - S2352-3964(16)30585-0 [pii]
LID - 10.1016/j.ebiom.2016.12.006 [doi]
AB  - Despite the significant global burden of gastroenteritis and resulting sequelae, 
      there is limited evidence on risk factors for sequelae development. We updated 
      and extended previous systematic reviews by assessing the role of antibiotics, 
      proton pump inhibitors (PPI) and symptom severity in the development of sequelae 
      following campylobacteriosis and salmonellosis. We searched four databases, 
      including PubMed, from 1 January 2011 to 29 April 2016. Observational studies 
      reporting sequelae of reactive arthritis (ReA), Reiter's syndrome (RS), irritable 
      bowel syndrome (IBS) and Guillain-Barre syndrome (GBS) following gastroenteritis 
      were included. The primary outcome was incidence of sequelae of interest amongst 
      cases of campylobacteriosis and salmonellosis. A narrative synthesis was 
      conducted where heterogeneity was high. Of the 55 articles included, incidence of 
      ReA (n=37), RS (n=5), IBS (n=12) and GBS (n=9) were reported following 
      campylobacteriosis and salmonellosis. A pooled summary for each sequela was not 
      estimated due to high level of heterogeneity across studies (I2>90%). PPI usage 
      and symptoms were sparsely reported. Three out of seven studies found a 
      statistically significant association between antibiotics usage and development 
      of ReA. Additional primary studies investigating risk modifying factors in 
      sequelae of GI infections are required to enable targeted interventions.
CI  - Copyright (c) 2016 The Authors. Published by Elsevier B.V. All rights reserved.
FAU - Esan, Oluwaseun B
AU  - Esan OB
AD  - Nuffield Department of Primary Care Health Sciences, University of Oxford, United 
      Kingdom; National Institute for Health Research, Health Protection Research Unit, 
      Gastrointestinal Infections, University of Oxford, United Kingdom. Electronic 
      address: oluwaseun.esan@phc.ox.ac.uk.
FAU - Pearce, Madison
AU  - Pearce M
AD  - National Institute for Health Research, Health Protection Research Unit, 
      Gastrointestinal Infections, University of Oxford, United Kingdom; Department of 
      Zoology, University of Oxford, United Kingdom.
FAU - van Hecke, Oliver
AU  - van Hecke O
AD  - Nuffield Department of Primary Care Health Sciences, University of Oxford, United 
      Kingdom.
FAU - Roberts, Nia
AU  - Roberts N
AD  - Bodleian Health Care libraries, University of Oxford, United Kingdom.
FAU - Collins, Dylan R J
AU  - Collins DRJ
AD  - Nuffield Department of Primary Care Health Sciences, University of Oxford, United 
      Kingdom.
FAU - Violato, Mara
AU  - Violato M
AD  - National Institute for Health Research, Health Protection Research Unit, 
      Gastrointestinal Infections, University of Oxford, United Kingdom; Health 
      Economics Research Centre, Nuffield Department of Population Health, University 
      of Oxford, United Kingdom.
FAU - McCarthy, Noel
AU  - McCarthy N
AD  - National Institute for Health Research, Health Protection Research Unit, 
      Gastrointestinal Infections, University of Oxford, United Kingdom; Department of 
      Zoology, University of Oxford, United Kingdom; Warwick Medical School, University 
      of Warwick, United Kingdom.
FAU - Perera, Rafael
AU  - Perera R
AD  - Nuffield Department of Primary Care Health Sciences, University of Oxford, United 
      Kingdom; National Institute for Health Research, Health Protection Research Unit, 
      Gastrointestinal Infections, University of Oxford, United Kingdom.
FAU - Fanshawe, Thomas R
AU  - Fanshawe TR
AD  - Nuffield Department of Primary Care Health Sciences, University of Oxford, United 
      Kingdom; National Institute for Health Research, Health Protection Research Unit, 
      Gastrointestinal Infections, University of Oxford, United Kingdom.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Review
PT  - Systematic Review
DEP - 20161208
PL  - Netherlands
TA  - EBioMedicine
JT  - EBioMedicine
JID - 101647039
RN  - 0 (Anti-Bacterial Agents)
RN  - 0 (PHB2 protein, human)
RN  - 0 (Prohibitins)
SB  - IM
MH  - Anti-Bacterial Agents/adverse effects/therapeutic use
MH  - *Campylobacter
MH  - Campylobacter Infections/*complications/diagnosis/drug therapy/*epidemiology
MH  - Gastroenteritis/complications/epidemiology/microbiology
MH  - Humans
MH  - Incidence
MH  - Prohibitins
MH  - Risk Factors
MH  - *Salmonella
MH  - Salmonella Infections/*complications/diagnosis/drug therapy/*epidemiology
PMC - PMC5233817
OTO - NOTNLM
OT  - Acid suppression
OT  - Antibiotics
OT  - Campylobacter
OT  - Gastroenteritis
OT  - Salmonella
OT  - Sequelae
EDAT- 2016/12/15 06:00
MHDA- 2017/02/15 06:00
PMCR- 2016/12/08
CRDT- 2016/12/15 06:00
PHST- 2016/11/09 00:00 [received]
PHST- 2016/12/06 00:00 [revised]
PHST- 2016/12/06 00:00 [accepted]
PHST- 2016/12/15 06:00 [pubmed]
PHST- 2017/02/15 06:00 [medline]
PHST- 2016/12/15 06:00 [entrez]
PHST- 2016/12/08 00:00 [pmc-release]
AID - S2352-3964(16)30585-0 [pii]
AID - 10.1016/j.ebiom.2016.12.006 [doi]
PST - ppublish
SO  - EBioMedicine. 2017 Feb;15:100-111. doi: 10.1016/j.ebiom.2016.12.006. Epub 2016 
      Dec 8.